MORRISVILLE, N.C. — TrialCard, a Morrisville-based pharmaceuticals technology solutions company, has announced the acquisition of RxSolutions for an undisclosed amount.
TrialCard was founded in 2000 and provides patient support services on behalf of pharmaceutical manufacturers.
Mark Bouck has served as president and CEO of TrialCard since 2013. He previously served as TrialCard’s executive vice president of business development.
“We are very impresssed with the business that RxSolutions has built and the culture they have maintained,” said Bouck in a statement. “RxSolutions is a great fit for TrialCard due to its affordability programs, longstanding presence in this space, and commitment to the patient.”
RxSolutions is based in Raleigh and specializes in customized pharmaceutical reimbursement-based programs for both marketing and clinical supply professionals.
One of RxSolutions’ most popular services is the RxStudy Card, which streamlines supply management for pharmaceutical manufacturers conducting clinical trials.
“We feel like the opportunity to join forces with a market leader like TrialCard is in the best interests of the brands that we support and the patients that we serve,” said RxSolutions President Tom Heck.
This story is from the North Carolina Business News Wire, a service of the UNC-Chapel Hill School of Media and Journalism